BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6572735)

  • 1. Establishment of a Ph1-positive human cell line (BV173).
    Pegoraro L; Matera L; Ritz J; Levis A; Palumbo A; Biagini G
    J Natl Cancer Inst; 1983 Mar; 70(3):447-53. PubMed ID: 6572735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen.
    Koshiba H; Minowada J; Pressman D
    J Natl Cancer Inst; 1978 Oct; 61(4):987-91. PubMed ID: 81309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a hairy cell leukemia cell line carrying Tac antigen and phagocytic activity with B-cell characteristics.
    Matsuo Y; Sagawa K; Morita M; Minowada J; Yokoyama MM
    J Natl Cancer Inst; 1986 Feb; 76(2):207-16. PubMed ID: 2418246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
    Negoro S; Seon BK
    Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia.
    Koníková E; Kusenda J; Babusíková O; Glasová M
    Neoplasma; 1995; 42(5):227-34. PubMed ID: 8552200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.
    Sugimoto T; Tatsumi E; Kemshead JT; Helson L; Green AA; Minowada J
    J Natl Cancer Inst; 1984 Jul; 73(1):51-7. PubMed ID: 6610792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New monoclonal antibodies SN3, SN3a, and SN3b directed to sialic acid of glycoprotein on human non-T leukemia cells.
    Fukukawa T; Matsuzaki H; Haruta Y; Hara H; Seon BK
    Exp Hematol; 1986 Oct; 14(9):850-5. PubMed ID: 3489635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue.
    Campana D; Janossy G; Bofill M; Trejdosiewicz LK; Ma D; Hoffbrand AV; Mason DY; Lebacq AM; Forster HK
    J Immunol; 1985 Mar; 134(3):1524-30. PubMed ID: 3918103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of Ph1-positive and Ph1-negative lymphoblastoid cell lines from a patient with chronic myelogenous leukemia.
    Yamada T; Sasaki M; Yoshida MC; Aya T; Koizumi S; Osato T
    Jpn J Cancer Res; 1985 May; 76(5):365-73. PubMed ID: 2989064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of thymus-derived lymphocyte markers in myelogenous leukemia (Ph1+) cell line K-562.
    Lozzio CB; Lozzio BB; Yang WK; Ichiki AT; Bamberger EG
    Cancer Res; 1976 Dec; 36(12):4657-62. PubMed ID: 63324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell markers in Ph1-positive acute lymphoblastic leukemia.
    Alimena G; De Rossi G; Gastaldi R; Guglielmi C; Mandelli F
    Nouv Rev Fr Hematol (1978); 1980; 22(3):275-80. PubMed ID: 6970921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel human pre-B leukemia cell line.
    Smith RG; Dev VG; Shannon WA
    J Immunol; 1981 Feb; 126(2):596-602. PubMed ID: 6778921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of HLA-DR antigens on leukaemic cells.
    Newman RA; Greaves MF
    Clin Exp Immunol; 1982 Oct; 50(1):41-50. PubMed ID: 6959750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic and ultrastructural heterogeneity of acute lymphoblastic leukemia-associated antigen-positive human leukemias.
    LeBien TW; Parkin JL; Brunning RD; Kersey JH
    J Natl Cancer Inst; 1980 Dec; 65(6):1231-6. PubMed ID: 6933270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage.
    Abramson CS; Kersey JH; LeBien TW
    J Immunol; 1981 Jan; 126(1):83-8. PubMed ID: 6969748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two t(9;22) leukemia cell lines (NALM-24 and NALM-25) with bi-phenotypic characteristics and an EBV-positive B-cell non-leukemia cell line (B262) established from a patient with acute lymphoblastic leukemia.
    Matsuo Y; Ariyasu T; Adachi T; Tsubota T; Minowada J
    Hum Cell; 1991 Dec; 4(4):339-42. PubMed ID: 1667895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of a common acute lymphoblastic leukemia cell line with a deletion of chromosome 3 band q26.
    Smith SD; Morgan R; Galili N; Amylon MD; Link MP; Hecht F; Sklar J; Glader BE
    Cancer Res; 1987 Mar; 47(6):1652-6. PubMed ID: 3469019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.